With technological advances in many facets of metabolic profiling, circulating amino acids, which involve insulin action via bidirectional modulation2,3, have been suggested to serve as novel biomarkers for predicting the risk of T2D, and perhaps to illuminate previously unknown pathways in diabetes pathophysiology3,4. The gene discussed is INS; the disease is diabetes mellitus.